// App-Quantinova.ai

e20666 : Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers.

Researchers

Presenter

  • Bob T. Li

Principal Investigators

  • Tao Zheng

  • Matthew David Hellmann

  • Emmet Jordan

  • David Barron

  • Lillian Mary Smyth

  • David B. Solit

  • Ahmet Zehir

  • Dara S. Ross

  • Michael F. Berger

  • Marc Ladanyi

  • Charles M. Rudin

  • Mark G. Kris

  • Maria E. Arcila

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved